CTLEW

General Information


DRACP ID  DRACP00584

Peptide Name   CTLEW

Sequence  CTLEW

Sequence Length  5

UniProt ID  Not available

PubChem CID  Not available

Origin  walnut residual protein

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma IC50=0.60±0.17 mg/mL MTT assay 48h 1
CaCo-2 Colon adenocarcinoma Carcinoma IC50=0.65±0.42 mg/mL MTT assay 48h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  IEC-6: IC50>4 mg/mL; spleen lymphocytes: IC50>4 mg/mL.

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00584

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C29H42N6O9S

Absent amino acids  ADFGHIKMNPQRSVY

Common amino acids  CELTW

Mass  72228

Pl  3.85

Basic residues  0

Acidic residues  1

Hydrophobic residues  2

Net charge  -1

Boman Index  -85

Hydrophobicity  24

Aliphatic Index  78

Half Life 
  Mammalian: 2.8 hour
  Yeast: 10 min
  E.coli: 2 min

Extinction Coefficient cystines  5500

Absorbance 280nm  1375

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 26593407

Title  Isolation of a novel bio-peptide from walnut residual protein inducing apoptosis and autophagy on cancer cells

Doi 10.1186/s12906-015-0940-9

Year  2015

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.